camptothecin has been researched along with Burkitt Lymphoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Georgieva, SG; Pankratova, EV; Portseva, TN; Stepchenko, AG | 1 |
| Greenberger, LM; Horak, ID; Kraft, P; Malaby, J; Mehlig, M; Sapra, P; Zhao, H | 1 |
| Ghetie, MA; Richardson, J; Tucker, K; Uhr, JW; Vitetta, ES | 1 |
| Giovanella, BC; Kozielski, AJ; Mendoza, J; Potmesil, M; Stehlin, JS; Vardeman, D | 1 |
| Chandan-Langlie, M; Chelstrom, LM; Evans, WE; Jin, J; Reaman, G; Stewart, CF; Uckun, FM; Waddick, KG; White, J | 1 |
| Akutsu, M; Kano, Y; Miura, Y; Suzuki, K; Tsunoda, S | 1 |
| Bieszczad, CK; Cleaveland, ES; Craig, RW; Ma, Y; Mohandas, TK; Park, JP; Vrana, JA | 1 |
1 trial(s) available for camptothecin and Burkitt Lymphoma
| Article | Year |
|---|---|
In vitro and in vivo activity of topotecan against human B-lineage acute lymphoblastic leukemia cells.
Topics: Adolescent; Adult; Animals; Antineoplastic Agents; Apoptosis; Burkitt Lymphoma; Camptothecin; Child; Child, Preschool; DNA Damage; Female; Humans; In Vitro Techniques; Male; Mice; Mice, SCID; Neoplasm Transplantation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Survival Analysis; Topoisomerase I Inhibitors; Topotecan | 1995 |
6 other study(ies) available for camptothecin and Burkitt Lymphoma
| Article | Year |
|---|---|
Increased level of Oct-1 protein in tumor cells modulates cellular response to anticancer drugs.
Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Burkitt Lymphoma; Camptothecin; Cell Line, Tumor; Dexamethasone; Gene Expression Regulation, Neoplastic; Humans; Octamer Transcription Factor-1; Protein Isoforms; Proto-Oncogene Proteins c-myc; RNA, Messenger; Transfection | 2016 |
Marked therapeutic efficacy of a novel polyethylene glycol-SN38 conjugate, EZN-2208, in xenograft models of B-cell non-Hodgkin's lymphoma.
Topics: Animals; Burkitt Lymphoma; Camptothecin; Cell Line, Tumor; Female; Humans; Lymphoma, B-Cell; Mice; Mice, SCID; Polyethylene Glycols; Xenograft Model Antitumor Assays | 2009 |
Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail.
Topics: Animals; Antigens, CD; Antigens, CD19; Antigens, Differentiation, B-Lymphocyte; Antineoplastic Agents; Burkitt Lymphoma; Camptothecin; Cell Adhesion Molecules; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Immunotoxins; Lectins; Mice; Mice, SCID; Ricin; Sialic Acid Binding Ig-like Lectin 2 | 1994 |
Growth inhibition of human cancer metastases by camptothecins in newly developed xenograft models.
Topics: Adenocarcinoma; Adrenal Gland Neoplasms; Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Burkitt Lymphoma; Camptothecin; Carcinoma, Squamous Cell; Drug Screening Assays, Antitumor; Humans; Liver Neoplasms; Male; Melanoma; Mice; Mice, Inbred Strains; Mice, Nude; Reproducibility of Results; Tumor Cells, Cultured | 1995 |
[Effects of SN-38 in combination with other anticancer agents against Dauji cells].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Camptothecin; Drug Screening Assays, Antitumor; Humans; Irinotecan; Tumor Cells, Cultured | 1994 |
An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Burkitt Lymphoma; Camptothecin; Cell Survival; Culture Media, Serum-Free; Cytarabine; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Etoposide; Humans; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Topoisomerase Inhibitors; Tumor Cells, Cultured | 2002 |